Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Xenon Pharmaceuticals Inc.

Clinical trials sponsored by Xenon Pharmaceuticals Inc., explained in plain language.

Xenon Pharmaceuticals Inc. XENE NASDAQ

A clinical-stage biopharmaceutical company developing neurology therapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 5 Not yet finished but already full! 3 Completed 1

New epilepsy drug shows promise in final stage trial

Disease control Completed

This Phase 3 trial tested a drug called XEN1101 (azetukalner) in 380 adults with focal-onset seizures that were not well-controlled by other medications. Participants took either XEN1101 or a placebo alongside their usual seizure drugs. The study measured whether XEN1101 reduced …

Phase: PHASE3 • Sponsor: Xenon Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:34 UTC